Search results for "pilot"

showing 10 items of 717 documents

Pilotpētījums par nazālo elpceļu obstrukcijas kvantitatīvo noteikšanu

2020

Pilotpētījums par nazālo elpceļu obstrukcijas kvantificēšanu Ievads Nazālā obstrukcija ir izplatīta problēma visā pasaulē, kas ievērojami ietekmē cilvēka dzīves kvalitāti. Neskatoties uz šīs problēmas prevalenci, pieejamās obstrukcijas pakāpes mērīšanas metodes ir neprecīzas. Ir novērota vāja korelācija starp kvantificēto obstrukcijas pakāpi, kas tiek iegūta lietojot mūsdienu metodes un kvalitatīvo obstrukcijas pakāpi, ko apraksta pacienti. Mērķis Šī ekperimentālā pētījuma mērķis ir, pirmkārt, radīt innovatīvu instrumentu, kas simulē specifiskas deguna obstrukcijas pakāpes. Tas būtu instruments, kas spētu potenciāli kvantificēt pacientu subjektīvās sajūtas par deguna obstrukciju. Otrkārt, m…

ObstructionNasalPsychophysicsPilotMedicīna
researchProduct

New pathways of increased cardiovascular risk in depression: a pilot study on the association of high-sensitivity C-reactive protein with pro-atheros…

2013

Abstract Background An elevation of inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) can be found in patients with depressive disorders. Inflammatory processes are known to influence atherosclerosis and might also mediate the link between depression and diabetes. The present study aimed at comparing hs-CRP and its relationship with atherogenic platelet markers in patients with type 2 diabetes (TD2) and/or newly diagnosed major depression (MD). Methods Hs-CRP concentrations in 24 patients with TD2, 21 patients with MD (diagnosed according to ICD-10 and DSM-IV), 19 patients with TD2 and comorbid MD, and 25 healthy controls were compared using analysis of variance. The…

OncologyAdultBlood PlateletsMalemedicine.medical_specialtyCD40 LigandMedizinPilot ProjectsType 2 diabetesDiseaseComorbidityRisk FactorsInternal medicineDiabetes mellitusmedicineHumansPlateletDepression (differential diagnoses)Depressive Disorder MajorCD40biologybusiness.industryC-reactive proteinMiddle Agedmedicine.diseaseAtherosclerosisPsychiatry and Mental healthClinical PsychologyEndocrinologyC-Reactive ProteinDiabetes Mellitus Type 2Cardiovascular DiseasesCase-Control Studiesbiology.proteinFemaleAnalysis of variancebusinessBiomarkersJournal of affective disorders
researchProduct

Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer.

2003

Although 5-fluorouracil remains the mainstay of treatment for advanced gastric cancer (AGC), no standard chemotherapy regimen exists. Combinations of irinotecan with folinic acid and infusional 5-fluorouracil (5-FU) (ILF) have shown good efficacy with acceptable toxicity in patients with metastatic colorectal cancer. At present, only sparse data on ILF are available for AGC. Therefore we conducted a prospective study of this combination in 25 consecutive patients with metastatic gastric cancer. Median age was 63 years, 10 had received prior chemotherapy and 13 presented initially with peritoneal carcinosis. Treatment consisted of irinotecan 80 mg/m2, folinic acid 500 mg/m2 and infusional 5-…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyLeucovorinPilot ProjectsIrinotecanFolinic acidStomach NeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansPharmacology (medical)In patientProspective StudiesAgedPharmacologybusiness.industryAdvanced gastric cancerMiddle AgedChemotherapy regimendigestive system diseasesIrinotecanstomatognathic diseasesOncologyFluorouracilToxicityCamptothecinFemaleFluorouracilbusinessmedicine.drugAnti-cancer drugs
researchProduct

Type A competitiveness traits correlate with downregulation of c-Fos expression in patients with type 1 diabetes.

2019

International audience; AimType A personality has been associated with increased survival in people with type 1 diabetes (T1D). Systemic low-grade inflammation may play a critical role, as suggested in recent reports, although the links between the inflammatory circulating transcriptome and Type A remain unknown. This prompted our exploration of the potential associations between Type A personality and c-Fos gene expression, a candidate gene closely linked to inflammatory processes, in T1D.MethodsType A personality was assessed by Bortner questionnaire in patients with T1D, and two subscales – ‘speed’ and ‘competitiveness’ – were used to measure these specific dimensions of Type A. Expressi…

OncologyAdultMalemedicine.medical_specialtyCandidate geneInverse AssociationCompetitive BehaviorEndocrinology Diabetes and MetabolismDown-RegulationGene Expression030209 endocrinology & metabolismPilot Projects030204 cardiovascular system & hematologyType ATranscriptomeCohort Studies03 medical and health sciencesddc:616.890302 clinical medicineEndocrinologyInternal medicineGene expressionInternal MedicinemedicineHumansGene[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismInflammationType 1 diabetesc-FosBlood Cellsbusiness.industryGene Expression ProfilingDiabetesType A and Type B personality theoryType A PersonalityGeneral Medicine[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle Agedmedicine.diseaseCompetitivenessDiabetes Mellitus Type 1businessBody mass indexProto-Oncogene Proteins c-fosDiabetic AngiopathiesPersonalityDiabetesmetabolism
researchProduct

A pilot study comparing different dose levels and administration schedules of interferon-α2b combined with epirubicin for prevention of recurrence in…

1992

A pilot study in 62 patients has been carried out to evaluate the combination of epirubicin and interferon (IFN)-alpha 2b using different doses and schedules of intravesical administration in the prevention of recurrence of bladder cancer. Preliminary results show greater prophylactic efficacy not only when higher doses of epirubicin and IFN-alpha 2b are used but also when a larger interval between instillation of the compounds was used.

OncologyCancer Researchmedicine.medical_specialtyAlpha interferonPilot ProjectsInterferon alpha-2Text miningRecurrenceInterferonInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansMedicinePharmacology (medical)EpirubicinPharmacologyBladder cancerbusiness.industryInterferon-alphamedicine.diseaseRecombinant ProteinsAdministration IntravesicalUrinary Bladder NeoplasmsOncologybusinessmedicine.drugEpirubicinAnti-Cancer Drugs
researchProduct

Tumor mutational burden on cytological samples: A pilot study.

2020

Background Immune-checkpoint inhibitors (ICIs) represent an important treatment option for patients who have advanced stage non-small cell lung cancer (NSCLC). Currently, evaluation of the expression level of programmed death-ligand 1 (PD-L1) has proven highly successful as a positive predictive biomarker for ICIs. In addition to PD-L1, other promising predictive biomarkers are emerging, including high tumor mutational burden (TMB-H). However, measuring TMB-H remains challenging for several reasons, among which is the difficulty in obtaining adequate tissue material from NSCLC patients. There are no data in the current literature regarding the possibility of adopting cell blocks (CBs) for T…

OncologyMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsCytological TechniquesDNA Mutational Analysis030209 endocrinology & metabolismPilot Projects03 medical and health sciences0302 clinical medicineInternal medicineCarcinoma Non-Small-Cell LungmedicineBiomarkers TumorHumansLung cancerPredictive biomarkerAgedRetrospective Studiesnext generation sequencingTMBbusiness.industryAdvanced stageTreatment optionsHigh-Throughput Nucleotide SequencingIon semiconductor sequencingAmpliconmedicine.diseasePrognosislung cancerOncology030220 oncology & carcinogenesisMutationcytologyTissue materialFemaleimmunotherapyNon small cellbusinessFollow-Up StudiesCancer cytopathologyReferences
researchProduct

A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck.

1993

Vinorelbine (VNR), 5′-nor-anhydrovinblastine, is a new semi-synthetic vinka alkaloid with selective affinity for mitotic microtubules, which has been shown to be active against several non small cell lung cancer lines in vitro [1]. VNR has been reported to yield a 34.7 % and 20 % overall response rate in patients with squamous cell lung carcinoma and bronchial adenocarcinoma respectively [2]. Moreover, VNR has been shown to be active in advanced breast carcinoma where it may induce a 30–50 % response rate depending on the extent of pretreatment [3]. We tested the activity and toxicity of single agent VNR given on a weekly schedule in a series of patients with recurrent and/or metastatic squ…

OncologyMaleCancer Researchmedicine.medical_specialtymedicine.drug_classAntineoplastic AgentsPilot ProjectsVinorelbineVinblastineVinca alkaloidInternal medicineCarcinomamedicineHumansHead and neckLung cancerMitosisbusiness.industryVinorelbineMiddle Agedmedicine.diseaseVinblastineOncologyHead and Neck NeoplasmsToxicityCarcinoma Squamous CellFemalebusinessmedicine.drugEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Blood flow and oxygenation status of human tumors. Clinical investigations.

1999

There is a large body of evidence suggesting that blood flow and oxygenation of human tumors are important research topics which may explain, in particular, resistance to radiation and to many antineoplastic drugs, which can limit the curability of solid tumors by radiotherapy and chemotherapy.This manuscript reviews the clinical investigations which have been performed regarding blood flow and oxygenation status of human tumors in radiation oncology.The possible uses and limitations of the prognostic significance and the changes under therapy measuring blood flow and oxygenation in human tumors were discussed. In addition, several approaches were summarized, which can improve the microvasc…

OncologyMalemedicine.medical_specialtyPathologymedicine.medical_treatmentCancer therapyHemodynamicsPilot ProjectsDrug resistanceMedical OncologyMicrocirculationInternal medicineNeoplasmsmedicineLaser-Doppler FlowmetryAnimalsHumansRadiology Nuclear Medicine and imagingUltrasonography Doppler ColorClinical OncologyChemotherapybusiness.industryMicrocirculationPatient SelectionResearchGastroenterologyDose fractionationRadiotherapy DosageBlood flowOxygenationNeoplasms ExperimentalPrognosisMagnetic Resonance ImagingCell HypoxiaRatsRadiation therapyOxygenOncologyDrug Resistance NeoplasmAntineoplastic DrugsRadiation OncologySurgeryFemaleDose Fractionation RadiationVascular functionbusinessStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
researchProduct

Expression of clec9a in the oral cancer microenvironment. A preliminary immunohistochemical pilot study

2021

Background The search for treatments to improve cancer survival has led to the emergence of immunotherapy and the study of the tumour microenvironment existing in neoplasms. This preliminary study aims to understand the clinical and pathological relationship of clec9a expression in oral cancer and to explore survival models for future studies. Material and methods: Immunohistochemical study that included 26 patients with a diagnosis of oral squamous cell carcinoma (OSCC) in mobile tongue and floor of the mouth. Clinical and histopathological variables were recorded, and the biomarkers clec9a for dendritic cells and CD8 and CD4 for lymphocytes were used. Results Clec9a was expressed in 58% o…

Oncologymedicine.medical_specialtymedicine.medical_treatmentPilot ProjectsInternal medicineOral Cancer and Potentially malignant disordersmedicineCarcinomaTumor MicroenvironmentHumansLectins C-TypepainGeneral DentistryPathologicalSurvival analysisUNESCO:CIENCIAS MÉDICASMouth neoplasmTumor microenvironmentbusiness.industryResearchquestionnaireCancerpsychometric validationImmunotherapymedicine.diseasePrognosisstomatognathic diseasesOtorhinolaryngologydisabilityHead and Neck NeoplasmsReceptors MitogenCarcinoma Squamous CellImmunohistochemistrySurgeryMouth Neoplasmshead and neck cancerbusiness
researchProduct

Optimum design and operation of primary sludge fermentation schemes for volatile fatty acids production.

2003

This paper presents a model-knowledge based algorithm for optimising the primary sludge fermentation process design and operation. This is a recently used method to obtain the volatile fatty acids (VFA), needed to improve biological nutrient removal processes, directly from the raw wastewater. The proposed algorithm consists in a heuristic reasoning algorithm based on the expert knowledge of the process. Only effluent VFA and the sludge blanket height (SBH) have to be set as design criteria, and the optimisation algorithm obtains the minimum return sludge and waste sludge flow rates which fulfil those design criteria. A pilot plant fed with municipal raw wastewater was operated in order to …

Optimal designEngineeringEnvironmental EngineeringWaste managementSewagebusiness.industryEcological ModelingProcess designFatty Acids VolatilePollutionWaste Disposal FluidAnaerobic digestionPilot plantWastewaterFacility Design and ConstructionFermentationProduction (economics)FermentationbusinessProcess engineeringWaste Management and DisposalEffluentAlgorithmsWater Science and TechnologyCivil and Structural EngineeringWater research
researchProduct